{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Obstructive+Pulmonary+Disease%2C+COPD&page=3", "query": { "condition": "Chronic Obstructive Pulmonary Disease, COPD", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 1231, "total_pages": 124, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Obstructive+Pulmonary+Disease%2C+COPD&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Obstructive+Pulmonary+Disease%2C+COPD&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-07T18:39:18.029Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01833390", "title": "MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma", "COPD", "Healthy" ], "interventions": [ { "name": "HXe MRI lung ventilation", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Xemed LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "21 Years to 75 Years" }, "enrollment_count": 58, "start_date": "2011-09", "completion_date": "2015-01", "has_results": false, "last_update_posted_date": "2015-03-11", "last_synced_at": "2026-10-07T18:39:18.029Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01833390" }, { "nct_id": "NCT00571792", "title": "Evaluation of Airway Gene Expression in COPD and Controlled Populations", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "COPD" ], "interventions": [], "intervention_types": [], "sponsor": "University of Nebraska", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "45 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "45 Years to 70 Years" }, "enrollment_count": 42, "start_date": "2006-09-01", "completion_date": "2011-02-01", "has_results": false, "last_update_posted_date": "2023-12-04", "last_synced_at": "2026-10-07T18:39:18.029Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT00571792" }, { "nct_id": "NCT00475007", "title": "Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Emphysema", "COPD" ], "interventions": [ { "name": "IBV® Valve System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Olympus Corporation of the Americas", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "40 Years to 74 Years" }, "enrollment_count": 277, "start_date": "2007-09", "completion_date": "2017-08", "has_results": false, "last_update_posted_date": "2018-04-17", "last_synced_at": "2026-10-07T18:39:18.029Z", "location_count": 34, "location_summary": "Birmingham, Alabama • Los Angeles, California • Mission Viejo, California + 29 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00475007" }, { "nct_id": "NCT03008356", "title": "L-carnitine for Fatigue in COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Copd", "Fatigue" ], "interventions": [ { "name": "L-carnitine 1000 mg twice daily", "type": "DIETARY_SUPPLEMENT" }, { "name": "Weekly health coaching calls", "type": "BEHAVIORAL" }, { "name": "Placebo capsules", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "BEHAVIORAL" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2017-01", "completion_date": "2018-02", "has_results": false, "last_update_posted_date": "2019-01-23", "last_synced_at": "2026-10-07T18:39:18.029Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03008356" }, { "nct_id": "NCT07780656", "title": "A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "GSK5784283", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Standard of care", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 624, "start_date": "2026-09-11", "completion_date": "2030-03-15", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-07T18:39:18.029Z", "location_count": 4, "location_summary": "Miami, Florida • Tampa, Florida • Rapid City, South Dakota + 1 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Rapid City", "state": "South Dakota" }, { "city": "West Point", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT07780656" }, { "nct_id": "NCT01494896", "title": "Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Arterial Hypertension", "Chronic Obstructive Pulmonary Disease" ], "interventions": [], "intervention_types": [], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 9, "start_date": "2011-11", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2015-05-07", "last_synced_at": "2026-10-07T18:39:18.029Z", "location_count": 3, "location_summary": "Jacksonville, Florida • Weston, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Weston", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01494896" }, { "nct_id": "NCT02661438", "title": "Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bronchiectasis", "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Placebo to Ciprofloxacin DPI (BAYQ3939)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 46, "start_date": "2016-01-12", "completion_date": "2016-03-17", "has_results": false, "last_update_posted_date": "2018-12-19", "last_synced_at": "2026-10-07T18:39:18.029Z", "location_count": 2, "location_summary": "Vero Beach, Florida • Jamaica, New York", "locations": [ { "city": "Vero Beach", "state": "Florida" }, { "city": "Jamaica", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02661438" }, { "nct_id": "NCT00773786", "title": "Effect of Brovana and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "COPD" ], "interventions": [ { "name": "Arformoterol (Brovana)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Trinity Health Of New England", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "40 Years to 90 Years" }, "enrollment_count": 20, "start_date": "2008-10", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2019-08-06", "last_synced_at": "2026-10-07T18:39:18.029Z", "location_count": 1, "location_summary": "Hartford, Connecticut", "locations": [ { "city": "Hartford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00773786" }, { "nct_id": "NCT05635266", "title": "Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Age-Related Macular Degeneration", "Allergies", "Alpha-Gal Syndrome", "Alzheimer Disease", "Amyloidosis", "Ankylosing Spondylitis", "Arthritis", "Alopecia Areata", "Asthma", "Atopic Dermatitis", "Autism", "Autoimmune Hepatitis", "Behcet's Disease", "Beta-Thalassemia", "Cancer", "Celiac Disease", "Kidney Diseases", "COPD", "Crohn Disease", "Cystic Fibrosis", "Diabetes", "Dravet Syndrome", "DMD", "Fibromyalgia", "Graves Disease", "Thyroid Diseases", "Hepatitis", "Hidradenitis Suppurativa", "ITP", "Leukemia", "ALS", "Lupus or SLE", "Lymphoma", "Multiple Sclerosis", "Myasthenia Gravis", "Heart Diseases", "Parkinson Disease", "Pemphigus Vulgaris", "Cirrhosis", "Psoriasis", "Schizophrenia", "Scleroderma", "Sickle Cell Disease", "Stroke", "Ulcerative Colitis", "Vasculitis", "Vitiligo" ], "interventions": [ { "name": "Specimen sample", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Sanguine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 20000, "start_date": "2021-10-26", "completion_date": "2025-10", "has_results": false, "last_update_posted_date": "2024-05-07", "last_synced_at": "2026-10-07T18:39:18.029Z", "location_count": 1, "location_summary": "Waltham, Massachusetts", "locations": [ { "city": "Waltham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05635266" }, { "nct_id": "NCT02734368", "title": "A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "Hyperpolarized Helium-3", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "40 Years to 70 Years" }, "enrollment_count": 53, "start_date": "2010-02", "completion_date": "2015-03", "has_results": false, "last_update_posted_date": "2016-04-12", "last_synced_at": "2026-10-07T18:39:18.029Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02734368" } ] }